# NEOPROFEN

NDC: 55292-122
Generic name: ibuprofen lysine
Labeler / Manufacturer: Recordati Rare Diseases Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20060413

FDA application: NDA021903

## Active ingredients

- IBUPROFEN LYSINE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55292-122"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55292-122
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f5ede6f-b0b7-4fc8-969e-652f60ead047